太阳集团tyc5997_平台(china)官方网站

胃泌素抑制肽(GIP)检测试剂盒DIY材料(酶联免疫吸附试验法)

ELISA Kit DIY Materials for Gastric Inhibitory Polypeptide (GIP)

Incretin hormone; Glucose Dependent Insulinotropic Peptide

  • 胃泌素抑制肽(GIP)检测试剂盒DIY材料(酶联免疫吸附试验法) 产品包装(模拟)
  • 胃泌素抑制肽(GIP)检测试剂盒DIY材料(酶联免疫吸附试验法) 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

试剂盒中的抗体对胃泌素抑制肽(GIP)具有高灵敏度和高特异性,经检测与其它相似物质无明显交叉反应。

用法

1.用100μL每孔的工作浓度的包被抗体包被96孔板,4度孵育过夜或者37度孵育2小时;
2.洗板1次;
3.用200μL每孔的工作浓度的封闭液,37度孵育1.5小时;
4.洗板1次。酶标板即可用于ELISA实验,后续使用方法与ELISA同。

储存

抗体,标准品和HRP标记的链霉亲和素在-20度保存,TMB需在4度保存,96孔板在室温保存。所有组分保质期为1年,试剂一旦开封,在4度保存时间为1个月。

配套试剂

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPA882Mu02 胃泌素抑制肽(GIP)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA882Mu01 胃泌素抑制肽(GIP)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
CPA882Mu11 胃泌素抑制肽(GIP)牛血清白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA882Mu21 胃泌素抑制肽(GIP)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
PAA882Mu02 胃泌素抑制肽(GIP)多克隆抗体 WB; IHC; ICC; IP.
PAA882Mu08 胃泌素抑制肽(GIP)多克隆抗体 WB; IHC; ICC; IP.
PAA882Mu01 胃泌素抑制肽(GIP)多克隆抗体 WB; IHC; ICC; IP.
MEA882Mu 胃泌素抑制肽(GIP)检测试剂盒(酶联免疫吸附试验法,小样本) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA882Mu 胃泌素抑制肽(GIP)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA882Mu 胃泌素抑制肽(GIP)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
KSA882Mu11 胃泌素抑制肽(GIP)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Scientific Reports The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlyingsignaling mechanisms in a rat model of diabetes mellitus. [pubmed:27721485]
Obesity surgery The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. [pubmed:28840471]
Obesity Surgery  Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague … [Pubmed:29098544]
BioMed Research International Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity []
Diabetes Research and Clinical Practice Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients [Pubmed: 31734225]
OBESITY SURGERY The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats [Pubmed: 31701411]
FUTURE SCIENCE Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes [Pubmed:35251693]
留言咨询
Baidu
sogou